We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Premaitha | LSE:NIPT | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.10 | 9.00 | 9.20 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/8/2016 16:46 | have a look at that 2 year chart above !! breakdown more like. | the monkster | |
18/8/2016 16:21 | Next Tuesday, Esperite release their interim results hxxp://www.esperite. Game on ! | brainspark1 | |
18/8/2016 12:12 | ha ha - only £25/- worth bought !! | the monkster | |
18/8/2016 11:52 | Gently now .... Is this a breakout .... | ramas | |
18/8/2016 10:37 | Next leg up | hamidahamida | |
18/8/2016 10:28 | ok cheers, that sounds good then! I know that Genoma were looking to do 40/50k unit sales in 2016, who knows it may be more now? | hjb1 | |
18/8/2016 09:55 | I meant Esperite's sales with respect to Tranquility, not their overall sales. | cl2201 | |
18/8/2016 09:50 | yes I know but it's only Genoma that sells NIPT amongst other things, so saying Esperite sales are good does not mean Genoma nipt sales are going like hot cakes does it? It may well be their other products...we don't know! | hjb1 | |
18/8/2016 09:31 | They're one and the same. | cl2201 | |
18/8/2016 09:26 | It's Genoma sales I am more interested in. | hjb1 | |
18/8/2016 09:06 | The main track being that Esperite's sales are supposedly very healthy, the full picture of which we should see in the coming weeks (September - unknown date). On a side note with the decision pending (within 6 weeks) for full scale NHS roll-out of NIPT, a go-ahead would see the shares rally (IMO) given the key involvement of Premaitha in the current small-scale operations with various NHS hospitals. | cl2201 | |
18/8/2016 08:54 | what "rumours" are those then? | hjb1 | |
18/8/2016 08:30 | I think this really needs to breach 11p in order to see a stronger outbreak, but that's just the technical view. On fundamentals (the reason I'm here) the company is hopefully looking solid (if rumours are true) - it will be interesting to see the update in the next few weeks. | cl2201 | |
18/8/2016 08:12 | Momemntum certainly switching to a positive one. Fingers crossed. | ngen yap | |
15/8/2016 08:11 | Friday 12 August 2016 Jeremy Hunt, the Health Secretary, is expected to respond to a recommendation from the National Screening Committee for the roll-out of NIPT tests within two months. | brainspark1 | |
11/8/2016 07:44 | 11 August 2016 "Whitehall sources said yesterday the Government was poised to approve the programme. Screening will cost the NHS 280 gbp per woman tested, compared with 650 gbp for amniocentesis." | brainspark1 | |
08/8/2016 09:13 | There is a buyer in the market hoovering all the sells | hamidahamida | |
05/8/2016 22:33 | Premathia have a fair list of events they are attending over the next few months starting with one towards the end of this month in Washington DC | kwizza | |
05/8/2016 17:29 | Out is the new Black? | small crow | |
05/8/2016 17:16 | BLack is out, share price is up -sounds good to me... | frenchfry | |
05/8/2016 16:50 | Strong finish at end supported by good buying | hamidahamida | |
05/8/2016 08:35 | I'm out again. May be back but i don't like the way this is fast becoming guess work. Management seem to be blowing in the wind. Either they have a strong case, a pot put aside to fight an action, the backing of thermo F and the will to see it through...........or they dont but its a fine line between a considered investment and an out and out Gamble and this is has become wobbly Good luck to all who hold. | blackss | |
05/8/2016 08:13 | I also think buying out premaitha is the best option for illumina to maintain monopoly. | hamidahamida |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions